Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia
PaperCitations, authors & open-access status
Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 250 citations, 2005 year and bronze oa status.
250
Citations
2005
Year
bronze
OA Status